Alzinova
Alzinova: Unique vaccine angle on Alzheimer’s (Redeye)
2019-01-23 07:30
Redeye initiates coverage of Alzinova, an early-stage biotech that develops a disease-modifying vaccine against Alzheimer’s disease. We view Alzinova’s vaccine candidate, ALZ-101, as scientifically and empirically strong and persuasive. There are several catalysts of importance for the stock, short- and mid-term.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se